Ä¢¹½tv

CAPABILITY | ECOLOGICAL & BIOLOGICAL SCIENCES

Environmental Risk Assessment for Pharmaceuticals & Veterinary Products

Various pharmaceuticals

Full-cycle environmental exposure and risk assessments

Gaining regulatory approval and meeting product defense requirements for pharmaceutical and veterinary products has become increasingly complex in the U.S. and EU. Ä¢¹½tv conducts environmental risk assessments for pharmaceuticals and veterinary products to evaluate fate and transport properties and develop potential exposure scenarios.

How does Ä¢¹½tv help clients assess the environmental impact of their pharmaceutical and veterinary products?

For decades, Ä¢¹½tv has helped clients with complex issues involving nanotechnology, endocrine disruptors, biologicals, genetically modified organisms, and traditional human and veterinary pharmaceuticals.

Our environmental toxicologists and regulatory specialists are involved in the global dialogue surrounding the detection of trace concentrations of pharmaceuticals in surface water, wastewater, and drinking water and the related issues of potential treatment, risk, and regulation. Our assessments range from simple justifications for categorical exclusion to complex multi-parameter, multi-receptor watershed-scale risk assessments.

Ä¢¹½tv delivers support at all phases:

  • Initial strategy development
  • Placement and monitoring of studies
  • Preparation of the environmental assessment
  • Regulatory submission and negotiations

Our Capabilities Are Unparalleled

With expertise in over 90 disciplines and hundreds of capabilities, tools, and methodologies — we get to the root of even the most complex challenges and give you the objective answers you need.